Feb 9 |
Prestige Consumer Healthcare Third Quarter 2024 Earnings: EPS Beats Expectations
|
Feb 8 |
Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript
|
Feb 8 |
Prestige Consumer Healthcare Inc. 2024 Q3 - Results - Earnings Call Presentation
|
Feb 8 |
Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024
|
Feb 8 |
Prestige Consumer Healthcare GAAP EPS of $1.06 beats by $0.02, revenue of $282.7M beats by $2.34M
|
Feb 8 |
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
|
Feb 7 |
Prestige Consumer Healthcare Q3 2024 Earnings Preview
|
Feb 2 |
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
|
Feb 1 |
Prestige Consumer Healthcare (PBH) Reports Next Week: What Awaits?
|
Jan 22 |
Verano Holdings Corp. (VRNOF) Surges 6.5%: Is This an Indication of Further Gains?
|